Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Anal cancer
Stage/Subtype:  stage II anal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-2 of 2 for your search:
Start Over
Nivolumab after Combined Modality Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: EA2165, NCI-2017-01347, NCT03233711
Radiation Therapy, Fluorouracil, and Mitomycin in Treating Patients with Stage I-IIIB Anal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-075, NCI-2013-01820, NCT01858025
Start Over